On Invalid Date, Journey Medical (NASDAQ: DERM) reported Q1 2023 earnings per share (EPS) of -$0.57, up 612.5% year over year. Total Journey Medical earnings for the quarter were -$10.14 million. In the same quarter last year, Journey Medical's earnings per share (EPS) was -$0.08.
As of Q2 2023, Journey Medical's earnings has grown year over year. Journey Medical's earnings in the past year totalled -$38.39 million.
What is DERM's earnings date?
Journey Medical's earnings date is Invalid Date. Add DERM to your watchlist to be reminded of DERM's next earnings announcement.
What was DERM's revenue last quarter?
On Invalid Date, Journey Medical (NASDAQ: DERM) reported Q1 2023 revenue of $12.21 million up 47.57% year over year. In the same quarter last year, Journey Medical's revenue was $23.30 million.
What was DERM's revenue growth in the past year?
As of Q2 2023, Journey Medical's revenue has grown -17.34% year over year. This is 23.8 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 6.46%. Journey Medical's revenue in the past year totalled $62.59 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.